Christina Fotopoulou
Overview
Explore the profile of Christina Fotopoulou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
217
Citations
4210
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Armbrust R, Fotopoulou C, Zocholl D, Chekerov R, Muallem M, Braicu I, et al.
Int J Gynecol Cancer
. 2025 Mar;
:101683.
PMID: 40057416
Objective: The phase III LION trial found no therapeutic benefit from systematic lymphadenectomy in patients with advanced ovarian cancer with optimal upfront cytoreduction and normal-appearing lymph nodes. Patients were randomized...
2.
Wengert G, Lu H, Aboagye E, Langs G, Poetsch N, Schwartz E, et al.
Eur Radiol
. 2024 Dec;
PMID: 39661150
Objectives: In women with high-grade serous ovarian cancer (HGSOC), a CT-based radiomic prognostic vector (RPV) predicted stromal phenotype and survival after primary surgery. The study's purpose was to fully externally...
3.
Fotopoulou C, Bowen R, Manchanda R, Michael A, McCormack S, Ullmann A, et al.
Future Oncol
. 2024 Nov;
21(1):95-103.
PMID: 39582319
To investigate current management of advanced epithelial ovarian cancer (OC) in the UK. A cross-sectional survey with 55 healthcare professionals involved in the care of OC patients was conducted via...
4.
Matias-Guiu X, Lax S, Raspollini M, Palacios J, Zheng W, Liu C, et al.
Eur J Cancer
. 2024 Nov;
213:115115.
PMID: 39520836
Incorporation of pathological and (not mandatory) molecular features into the new FIGO 2023 staging system has generated some controversy. Several validations have been published recently that demonstrated the higher prognostic...
5.
Kim J, Kim S, Park E, Ha H, Kim J, Coleman R, et al.
Gynecol Oncol
. 2024 Nov;
179:24-32.
PMID: 39491079
Background: Current treatment strategies for primary epithelial ovarian cancer (EOC) have significantly evolved, and the value of complete cytoreduction has not yet been reassessed. The study aimed to investigate the...
6.
Nikolova T, Bilir E, Bizzarri N, Fotopoulou C, Van Gorp T, Kacperczyk-Bartnik J, et al.
Int J Gynecol Cancer
. 2024 Oct;
34(11):1685-1690.
PMID: 39395820
No abstract available.
7.
Angeles M, Agusti N, Bonaldo G, Bizzarri N, Bilir E, Piedimonte S, et al.
Int J Gynecol Cancer
. 2024 Aug;
34(10):1522-1528.
PMID: 39181697
In March 2024, 12 European Network of Young Gynae Oncologists- (ENYGO-IJGC) Editorial Fellows conducted 10 interviews with senior opinion leaders on original and controversial topics in the field of gynecologic...
8.
Cooper N, Al-Memar M, Linton-Reid K, Edmonds K, Rose G, Dixon N, et al.
BJOG
. 2024 Aug;
132(1):64-71.
PMID: 39129596
Objective: To correlate the clinical history with imaging findings of women with Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome. Design: Retrospective cohort study. Setting: A UK IOTA and ESGO-certified tertiary referral centre for disorders...
9.
Moss E, Taylor A, Andreou A, Ang C, Arora R, Attygalle A, et al.
Eur J Obstet Gynecol Reprod Biol
. 2024 Jul;
300:69-123.
PMID: 39002401
No abstract available.
10.
Nasser S, Fotopoulou C, Gultekin M, Dimitrova D, Bilir E, Inci G, et al.
Arch Gynecol Obstet
. 2024 Jun;
310(1):577-586.
PMID: 38836928
Purpose: Our prospective international survey evaluated the impact of the early phase of the COVID-19 pandemic on the management gynaecological malignancies from the multidisciplinary physicians' perspective with particular focus on...